Cite
Woitek R, McLean MA, Ursprung S, et al. Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer Patients. Cancer Res. 2021;81(23):6004-6017doi: 10.1158/0008-5472.CAN-21-1499.
Woitek, R., McLean, M. A., Ursprung, S., Rueda, O. M., Manzano Garcia, R., Locke, M. J., Beer, L., Baxter, G., Rundo, L., Provenzano, E., Kaggie, J., Patterson, A., Frary, A., Field-Rayner, J., Papalouka, V., Kane, J., Benjamin, A. J. V., Gill, A. B., Priest, A. N., Lewis, D. Y., Russell, R., Grimmer, A., White, B., Latimer-Bowman, B., Patterson, I., Schiller, A., Carmo, B., Slough, R., Lanz, T., Wason, J., Schulte, R. F., Chin, S. F., Graves, M. J., Gilbert, F. J., Abraham, J. E., Caldas, C., Brindle, K. M., Sala, E., & Gallagher, F. A. (2021). Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer Patients. Cancer research, 81(23), 6004-6017. https://doi.org/10.1158/0008-5472.CAN-21-1499
Woitek, Ramona, et al. "Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer Patients." Cancer research vol. 81,23 (2021): 6004-6017. doi: https://doi.org/10.1158/0008-5472.CAN-21-1499
Woitek R, McLean MA, Ursprung S, Rueda OM, Manzano Garcia R, Locke MJ, Beer L, Baxter G, Rundo L, Provenzano E, Kaggie J, Patterson A, Frary A, Field-Rayner J, Papalouka V, Kane J, Benjamin AJV, Gill AB, Priest AN, Lewis DY, Russell R, Grimmer A, White B, Latimer-Bowman B, Patterson I, Schiller A, Carmo B, Slough R, Lanz T, Wason J, Schulte RF, Chin SF, Graves MJ, Gilbert FJ, Abraham JE, Caldas C, Brindle KM, Sala E, Gallagher FA. Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer Patients. Cancer Res. 2021 Dec 01;81(23):6004-6017. doi: 10.1158/0008-5472.CAN-21-1499. Epub 2021 Oct 08. PMID: 34625424; PMCID: PMC7612070.
Copy
Download .nbib